| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.3B | $2.6B | $2.8B | $2.3B | $2.3B | $2.1B | $1.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B |
| SG&A Expense | $1.2B | $1.9B | $0.7B | $0.7B | $0.5B | $0.5B | $0.5B | $0.4B |
| Operating Income | $-0.1B | $-0.9B | $-0.2B | $0.0B | $0.1B | $0.0B | $-0.1B | $-0.1B |
| Net Income | $-0.6B | $-1.1B | $1.1B | $-0.0B | $0.0B | $0.0B | $-0.1B | $-0.1B |
| EPS (Basic) | $-4.48 | $-9.12 | $14.29 | $-0.21 | $0.06 | $0.00 | $-1.13 | $-1.15 |
| EPS (Diluted) | $-4.48 | $-9.12 | $14.29 | $-0.21 | $0.06 | $0.00 | $-1.13 | $-1.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.4B | $16.3B | $7.7B | $6.4B | $5.3B | $4.9B | $3.9B | $3.4B |
| Current Assets | $2.9B | $3.5B | $2.2B | $1.2B | $1.0B | $1.0B | $0.9B | $0.6B |
| Cash & Equivalents | $1.6B | $1.9B | $1.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.1B |
| Total Liabilities | $10.8B | $11.3B | $3.9B | $3.7B | $3.0B | $2.8B | $2.0B | $1.6B |
| Current Liabilities | $1.7B | $1.3B | $1.0B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B |
| Stockholders' Equity | $4.6B | $5.0B | $3.8B | $2.6B | $2.4B | $2.0B | $1.9B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.7B | $0.4B | $0.5B | $0.7B | $0.4B | $0.3B | — |
| Investing Cash Flow | $-0.8B | $-1.3B | $0.8B | $-1.1B | $-0.9B | $-0.8B | $-0.5B | — |
| Capital Expenditures | — | — | $1.1B | $0.9B | $0.8B | $0.7B | $0.6B | $0.5B |
| Financing Cash Flow | $-0.4B | $1.1B | $-0.1B | $0.6B | $0.1B | $0.4B | $0.4B | — |